The growth of Viagra and its influence on the drug landscape presents a complicated question for traders. While the early sales statistics were astounding, the patent has ended, leading to a wave of off-brand alternatives that are chipping away at revenue. Furthermore, the market is facing difficulties related to aging trends and evolving healthcar